Search

Kathleen Kahler Fonda

Examiner (ID: 237)

Most Active Art Unit
1623
Art Unit(s)
1803, 1623, 1211, 1622, 1621
Total Applications
685
Issued Applications
444
Pending Applications
93
Abandoned Applications
148

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3795369 [patent_doc_number] => 05780606 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Neisseria meningitidis capsular polysaccharide conjugates' [patent_app_type] => 1 [patent_app_number] => 8/474392 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7135 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780606.pdf [firstpage_image] =>[orig_patent_app_number] => 474392 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/474392
Neisseria meningitidis capsular polysaccharide conjugates Jun 6, 1995 Issued
08/485328 PROCESS FOR PREPARING ENCAPSULATED WATER SOLUBLE BETA-CAROTENE Jun 6, 1995 Abandoned
Array ( [id] => 3505757 [patent_doc_number] => 05514660 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Method for treating and inhibiting gastric and duodenal ulcers' [patent_app_type] => 1 [patent_app_number] => 8/474199 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6295 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514660.pdf [firstpage_image] =>[orig_patent_app_number] => 474199 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/474199
Method for treating and inhibiting gastric and duodenal ulcers Jun 6, 1995 Issued
Array ( [id] => 3658382 [patent_doc_number] => 05624679 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine biological barriers' [patent_app_type] => 1 [patent_app_number] => 8/470083 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 74 [patent_no_of_words] => 35411 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624679.pdf [firstpage_image] =>[orig_patent_app_number] => 470083 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/470083
Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine biological barriers Jun 5, 1995 Issued
Array ( [id] => 3623695 [patent_doc_number] => 05686115 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Poly-.beta.-1.fwdarw.4-N-acetylucosamine copolymer composition with collagen' [patent_app_type] => 1 [patent_app_number] => 8/470912 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 72 [patent_no_of_words] => 35378 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686115.pdf [firstpage_image] =>[orig_patent_app_number] => 470912 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/470912
Poly-.beta.-1.fwdarw.4-N-acetylucosamine copolymer composition with collagen Jun 5, 1995 Issued
Array ( [id] => 3516220 [patent_doc_number] => 05576305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Intercellular adhesion mediators' [patent_app_type] => 1 [patent_app_number] => 8/466040 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 26 [patent_no_of_words] => 20856 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576305.pdf [firstpage_image] =>[orig_patent_app_number] => 466040 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/466040
Intercellular adhesion mediators Jun 5, 1995 Issued
Array ( [id] => 3731079 [patent_doc_number] => 05635493 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine chemotherapeutics' [patent_app_type] => 1 [patent_app_number] => 8/471545 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 73 [patent_no_of_words] => 35361 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635493.pdf [firstpage_image] =>[orig_patent_app_number] => 471545 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/471545
Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine chemotherapeutics Jun 5, 1995 Issued
Array ( [id] => 3837993 [patent_doc_number] => 05846952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine drug delivery' [patent_app_type] => 1 [patent_app_number] => 8/470077 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 73 [patent_no_of_words] => 35418 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846952.pdf [firstpage_image] =>[orig_patent_app_number] => 470077 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/470077
Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine drug delivery Jun 5, 1995 Issued
Array ( [id] => 3770259 [patent_doc_number] => 05849721 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/467657 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4652 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849721.pdf [firstpage_image] =>[orig_patent_app_number] => 467657 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/467657
Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof Jun 5, 1995 Issued
Array ( [id] => 3770273 [patent_doc_number] => 05849722 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Oligosaccharide having affinity for fibroblast growth factor and process for producing same' [patent_app_type] => 1 [patent_app_number] => 8/471174 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5653 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849722.pdf [firstpage_image] =>[orig_patent_app_number] => 471174 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/471174
Oligosaccharide having affinity for fibroblast growth factor and process for producing same Jun 5, 1995 Issued
Array ( [id] => 3856836 [patent_doc_number] => 05705493 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Oligosaccharides having biological activity and preparation of same from supersulfated dermatan' [patent_app_type] => 1 [patent_app_number] => 8/481282 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6984 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705493.pdf [firstpage_image] =>[orig_patent_app_number] => 481282 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/481282
Oligosaccharides having biological activity and preparation of same from supersulfated dermatan Jun 5, 1995 Issued
Array ( [id] => 3770025 [patent_doc_number] => 05733892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Metastasis inhibitor composition comprising a phospholipid-linked glycosaminoglycan and method for inhibiting metastasis employing the same' [patent_app_type] => 1 [patent_app_number] => 8/469930 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14507 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733892.pdf [firstpage_image] =>[orig_patent_app_number] => 469930 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/469930
Metastasis inhibitor composition comprising a phospholipid-linked glycosaminoglycan and method for inhibiting metastasis employing the same Jun 5, 1995 Issued
Array ( [id] => 3706205 [patent_doc_number] => 05654282 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Selectin binding glycopeptides' [patent_app_type] => 1 [patent_app_number] => 8/468887 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 13122 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654282.pdf [firstpage_image] =>[orig_patent_app_number] => 468887 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/468887
Selectin binding glycopeptides Jun 5, 1995 Issued
Array ( [id] => 3809155 [patent_doc_number] => 05811410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID' [patent_app_type] => 1 [patent_app_number] => 8/465335 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19755 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811410.pdf [firstpage_image] =>[orig_patent_app_number] => 465335 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/465335
Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID Jun 4, 1995 Issued
Array ( [id] => 3805901 [patent_doc_number] => 05830882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition' [patent_app_type] => 1 [patent_app_number] => 8/462615 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19745 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830882.pdf [firstpage_image] =>[orig_patent_app_number] => 462615 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/462615
Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition Jun 4, 1995 Issued
Array ( [id] => 3613915 [patent_doc_number] => 05510333 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation' [patent_app_type] => 1 [patent_app_number] => 8/462456 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10289 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510333.pdf [firstpage_image] =>[orig_patent_app_number] => 462456 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/462456
Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation Jun 4, 1995 Issued
Array ( [id] => 3850736 [patent_doc_number] => 05767093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Methods for attenuating antibody-mediated xenograft rejection in human recipients' [patent_app_type] => 1 [patent_app_number] => 8/460094 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 10950 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767093.pdf [firstpage_image] =>[orig_patent_app_number] => 460094 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/460094
Methods for attenuating antibody-mediated xenograft rejection in human recipients Jun 1, 1995 Issued
Array ( [id] => 3701190 [patent_doc_number] => 05646131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Method for solubilizing drugs using cyclodextrins and carboxylic acids' [patent_app_type] => 1 [patent_app_number] => 8/460631 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5860 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646131.pdf [firstpage_image] =>[orig_patent_app_number] => 460631 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/460631
Method for solubilizing drugs using cyclodextrins and carboxylic acids Jun 1, 1995 Issued
Array ( [id] => 3628418 [patent_doc_number] => 05686431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Methods of using low molecular weight heparins for treatment of pathological processes' [patent_app_type] => 1 [patent_app_number] => 8/457655 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7297 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686431.pdf [firstpage_image] =>[orig_patent_app_number] => 457655 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/457655
Methods of using low molecular weight heparins for treatment of pathological processes May 31, 1995 Issued
Array ( [id] => 3808987 [patent_doc_number] => 05831081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Process for the purification of water-soluble cyclodextrin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/454940 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4024 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831081.pdf [firstpage_image] =>[orig_patent_app_number] => 454940 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/454940
Process for the purification of water-soluble cyclodextrin derivatives May 30, 1995 Issued
Menu